Compare Core Scientific Inc (CORZ) vs Freeport-McMoRan Inc (FCX) Price & Performance

Core Scientific (CORZ) trades at $20.87, up 5.62% today, amid strong analyst optimism with 86% buy ratings and a $35.71 consensus price target. The stock shows bearish technical signals but benefits from recent AI infrastructure partnerships, including a major deal with AMD for up to 2.5 gigawatts of data center capacity. Despite negative profitability metrics, revenue growth is projected from $319M in 2025 to $440M in 2026, driven by high-density colocation services.

The outlook is mixed: significant growth potential exists from AI-driven demand and long-term contracts, but high cash burn and negative margins pose risks. Investors should weigh the bullish analyst sentiment against fundamental challenges, including a net income margin of -324.9% and substantial earnings misses in recent quarters.

FCX trades at $66.83, down 2.98% on the day, but maintains a bullish technical trend with strong analyst support. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 expected at $0.72 EPS. Revenue remains stable around $25.9B, while net income margin improved to 11.38% in 2026. Recent news highlights operational challenges like lower copper volumes but also growth initiatives at Grasberg and Bagdad.

The outlook is positive with a consensus price target of $73.85, implying ~10% upside. Key opportunities include exposure to high copper prices and expansion projects, while risks involve production volatility, cost pressures, and reliance on commodity cycles. The stock's valuation appears elevated with a P/E of 33.93, requiring sustained earnings growth to justify further gains.